Oxaliplatin and Capecitabine on Top of Sorafenib Versus Sorafenib Alone in Advanced Hepatocellular Carcinoma Patients

Clinical trial NCT01245582 · WITHDRAWN

Trial details

NCT number: NCT01245582
Sponsor: Sanofi
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatic Neoplasm Malignant

Start date: 2011-07-01
Primary completion: 2014-02-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.